Echo Therapeutics

Echo Therapeutics Announces Needle-free Glucose Monitoring System

The company has patented its Symphony tCGM glucose monitoring system, and the Prelude SkinPrep transdermal drug delivery product.

Echo Therapeutics Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude SkinPrep System for transdermal drug delivery, today announced the receipt of a notice of allowance for a patent application covering its Prelude SkinPrep System and a notice of issuance for a patent covering its Symphony tCGM System.

No votes yet
Syndicate content